Progyny, Inc.

NASDAQ:PGNY

Medical - Healthcare Information Services

Healthcare
$36.16 -0.19%

-$0.05 today

Market cap
$2.66B
Beta
1.04
P/E (TTM)
31.4
EPS (TTM)
$0.84
52W Low $16.10High $28.75

Volume 0.88M

Average 1.49M

PGNY Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Progyny, Inc.NASDAQ: PGNY

Gross Profit · Q2 FY2026 · quarter ended Jun 2026

Gross profit grows, but more slowly than its trailing trend

Q2 FY2026 gross profit of $89.3M rose 13.1% year over year, behind the +16.1% change in trailing-twelve-month gross profit. Sequentially, it rose 7.5% from the prior quarter. Over 3 fiscal years it compounded at +22.1% a year.

Context

  • Gross profit amounted to 23.6% of revenue in FY2025, up 1.9 pp from a year earlier.
  • Gross profit increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +13.1% toward the trailing-twelve-month pace of +16.1%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$89.3M+7.5% QoQ
Last fiscal yearDec 2025
$304.48M+20.2% YoY
LTMJun 2026
$322.09M+16.1% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+13.1%——
1 year+20.2%——
3-year CAGR+22.1%——
5-year CAGR——
10-year CAGR——

Gross Profit history

USD · from the income statement

Latest · FY2025
304.48M USD
Year-over-year change
+20.2%
4-year CAGR
+28.4%

Gross Profit vs competitors

How PGNY compares with its peers on the latest reported figures

  • PGNY's LTM Jun 2026 gross profit of $322.09M is the 2nd highest of the 3 companies compared; the peer median is $606.04M.
  • Its year-over-year change of +16.1% is the lowest of 3, against a peer median of +47.5%.
  • Gross profit amounts to 24.6% of revenue for PGNY, versus a peer median of 70.7%.
PGNY Competitors Peer median
Gross Profit for PGNY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HQYHealthEquity, Inc.LTM Jul 2026$1.02B +34.7%+32.2%75.2%
PGNYProgyny, Inc.LTM Jun 2026$322.09M +16.1%+22.1%24.6%
OMDAOmada HealthLTM Mar 2026$187.61M +60.4%+58.7%66.2%
Peer median (excluding PGNY) $606.04M+47.5%+45.4%70.7%

Competitors are the stored peer set for PGNY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue500.62M786.91M1.09B1.17B1.29B
Cost of Revenue388.49M619.59M849.8M913.86M984.18M
Gross Profit112.14M167.33M238.8M253.36M304.48M
Gross Margin22.4%21.3%21.9%21.7%23.6%
Research & Development00000
Selling, General & Admin79.8M143.98M176.62M185.91M219.21M
Operating Expenses79.8M143.98M176.62M185.91M219.21M
Depreciation & Amortization1.3M1.6M2.28M3.18M4.95M
EBITDA33.74M26.04M72.97M86.38M100.38M
EBITDA Margin6.7%3.3%6.7%7.4%7.8%
Operating Income32.34M23.34M62.18M67.46M85.28M
Operating Margin6.5%3.0%5.7%5.8%6.6%
Interest Income461K814K8.51M15.75M10.16M
Interest Expense00000
Other Income / Expenses95K1.1M8.51M15.75M10.16M
Income Before Tax32.44M24.44M70.69M83.2M95.43M
Pre-Tax Margin6.5%3.1%6.5%7.1%7.4%
Income Tax Expense(33.33M)(5.92M)8.65M28.87M36.91M
Net Income65.77M30.36M62.04M54.34M58.52M
Net Margin13.1%3.9%5.7%4.7%4.5%
EPS (Basic)0.740.330.650.590.68
EPS (Diluted)0.660.300.620.570.65
Weighted Avg Shares89.11M92.2M95.02M91.48M85.23M
Weighted Avg Shares (Diluted)100.36M99.96M100.67M95.45M89.46M

Progyny, Inc.

NASDAQ:PGNY

Intrinsic Alpha fair value

Locked

Current Price

$36.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.